About TCI
TCI is a company based in Taipei (Taiwan) founded in 1980. It operates as a Direct-to-Consumer (D2C) and Private Labeling / White Label. TCI offers products and services including Functional Health Foods, Skincare Products, and Dietary Supplements. TCI operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
- Headquarter Taipei, Taiwan
- Stage Public
- SectorsHealthcare
- Website category Business and Consumer Services · Textiles
- Email••••••••
- Phone•••• ••••
- Website tci-bio.com
- Social LinkedIn X Facebook
- Legal Name Tci Co., Ltd.
- Annual Revenue$6.99 B-3.47as on Dec 31, 2025
- Net Profit$954.96 M12.15as on Dec 31, 2025
- EBITDA$1.73 B6.21as on Dec 31, 2025
Products & Services of TCI
TCI offers a comprehensive portfolio of products and services, including Functional Health Foods, Skincare Products, and Dietary Supplements.
Functional health foods are developed for consumer wellness.
Skincare products are manufactured for global beauty markets.
Dietary supplements are produced for health enhancement needs.
IPO & Listings of TCI
TCI is a publicly listed company on the TPEX with ticker symbol 8436 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date12 Sep 2013
- Listed onTT: 8436
- Listed entityTCI Co., Ltd.
- Exchange sectorHealth technology
- ISINTW0008436007
- Share price103.00 TWD (+0.49% on the day) · 2026-10-08
- Market capitalisation11,932,429,611.00 TWD
- Price to earnings11.0
- EPS (diluted, trailing year)9.41 TWD
- Dividend yield5.84%
- Volume (last session)324,886
Financials of TCI
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.99B TWD | 955.0M TWD | 1.73B TWD |
| 2024 | 7.24B TWD | 851.5M TWD | 1.63B TWD |
| 2023 | 8.02B TWD | 896.3M TWD | 1.70B TWD |
| 2022 | 7.43B TWD | 713.5M TWD | 1.65B TWD |
| 2021 | 8.58B TWD | 1.55B TWD | 2.19B TWD |
Detailed financial statements for TCI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of TCI
TCI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Curia and AmplifyBio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novartis.com | 1996 | Basel, Switzerland | – | 97 | R&D focused on manufacturing of drugs for multiple therapeutic areas | |
| catalent.com | 2007 | Somerset, United States | – | 9,390 | CDMO offering drug and biologics development services | |
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | – | 1,918 | Drug research, development, testing, and consulting services are provided. | |
| amplify-bio.com | 2021 | Hilliard, United States | $229.75M | – | Provides contract research, development, and manufacturing services for biologic drugs. | |
| wuxibiologics.com | 2008 | Shanghai, China | – | 257 | Protein therapeutics are developed and manufactured by WuXi Biologics. | |
| samsungbiologics.com | 2011 | Incheon, South Korea | – | – | Contract development and manufacturing for biologics are provided. | |
| indapta.com | 2016 | Seattle, United States | $72.5M | – | Limited information available | |
| ventustx.com | 2019 | Boston, United States | $300M | 1 | Small-molecule therapeutics are developed for autoimmune and auto-inflammatory diseases. |
Detailed competitors of TCI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TCI
The website of TCI (tci-bio.com) receives about 139.9K visits a month and ranks #204,403 among all websites worldwide, #5,637 in Textiles.
- Monthly visits139.9K
▼ 22.2% vs previous month
- Unique visitors53.3K
per month
- Global rank#204,403
among all websites
- Category rank#5,637
Business and Consumer Services · Textiles
- Bounce rate37%
- Pages per visit4.3
- Average visit3 min 20 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with TCI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
irati.fr | irati.fr | 100% | – | #8,695,576 | – |
tyoemcosmetic.com | tyoemcosmetic.com | 100% | – | #1,063,699 | – |
vitaminlabs.eu | vitaminlabs.eu | 100% | – | #4,963,413 | – |
gii.tw | gii.tw | 100% | – | #816,347 | – |
| supliful.com | 100% | 310.1K | #100,919 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for TCI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Tci
Complete news archive for TCI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to TCI
10 companies that operate in the same segment as TCI (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TCI
TCI was founded in 1980.
TCI is headquartered in Taipei, Taiwan.
TCI is involved in the development and production of functional health foods, dietary supplements, and skincare products. The company operates in the global beauty and wellness sector, offering customized and predesign solutions. Comprehensive supply chain services are provided to meet client needs. Emphasis is placed on sustainability through zero-carbon manufacturing and solar energy use. Innovation is driven by scientific research and consumer insights, accelerating product development significantly.
TCI offers Functional Health Foods, Skincare Products, and Dietary Supplements.
Yes, TCI is publicly traded on TPEX under the ticker symbol 8436.
TCI operates through Tci Co., Ltd..
The website of TCI receives about 140 thousand visits a month and ranks #204,403 among all websites worldwide.